Testing of the maternal sample is required by law. The diseases assessed for have been identified as being potentially hazardous in a transfusion/transplant setting. At present, these are HIV I and II, HTLV (Human T cell Lymphotrophic Virus), Syphilis, Hepatitis B and Hepatitis C.
